Inici › Limfoma › Illinois › Chicago
Assaigs clínics de Limfoma a Chicago, IL
20 estudis de Limfoma busquen participants en centres de Chicago i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
ReclutantFase 2
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
ReclutantFase 1/2
- Lurie Children's Hospital-Chicago, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
ReclutantFase 3
- Research Site, Chicago
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ReclutantFase 1
- University of Illinois Cancer Center, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
ReclutantFase 1/2
- University of Chicago, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
ReclutantFase 1/2
- University of Chicago Medical Center, Chicago
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
ReclutantFase 1
- The David and Etta Jonas Center for Cellular Therapy, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
ReclutantFase 3
- Northwestern, Chicago
- University of Chicago, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Reclutant
- Northwestern University Feinberg School of Medicine, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
ReclutantFase 2
- Robert H Lurie Cancer Center, Chicago
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
ReclutantFase 1/2
- Call for Information (Investigational Site 0024), Chicago
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutantFase 1
- Northwestern University, Chicago
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
ReclutantEstudi observacional
- Lurie Children's Hospital-Chicago, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ReclutantFase 1/2
- Northwestern Memorial Hospital, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
ReclutantFase 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutantFase 1
- The University of Chicago Medical Center, Chicago
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
ReclutantFase 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Reclutant
- University of Chicago Comprehensive Cancer Center, Chicago
Avo In R/R And Previously Untreated MCL
ReclutantFase 1/2
- University of Chicago Medical Center, Chicago
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
ReclutantFase 1
- Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
Assaigs de Limfoma en altres ciutats
- Houston, TX34 estudis
- Boston, MA33 estudis
- New York City, NY33 estudis
- Washington, DC23 estudis
- Baldwin Park, CA21 estudis
- Durham, NC17 estudis
- St. Louis, MO15 estudis
- Philadelphia, PA15 estudis
- Cleveland, OH14 estudis
- Edison, NJ12 estudis
- Atlanta, GA12 estudis
- Seattle, WA12 estudis
Altres estudis a Chicago
- Càncer de pulmó de cèl·lules no petites61 estudis
- Càncer de mama58 estudis
- Càncer (tots els tipus)51 estudis
- Càncer metastàtic45 estudis
- Càncer de pròstata45 estudis
- Obesitat41 estudis
- Càncer de pulmó41 estudis
- Càncer d'ovari36 estudis
- Ictus34 estudis
- Càncer colorrectal33 estudis
- Insuficiència cardíaca31 estudis
- Sobrepès28 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.